Lv5
1120 积分 2024-01-20 加入
红
Step-down treatment with mepolizumab for eosinophilic granulomatosis with polyangiitis: a real-life single-centre study
1个月前
已完结
Excessive Dynamic Airway Collapse
2个月前
已关闭
Early Treatment Response to Mepolizumab Predicts Clinical Remission in Severe Eosinophilic Asthma
2个月前
已完结
Factors Linked to Injection Interval Extension in Eyes with Wet Age-Related Macular Degeneration Switched to Brolucizumab
4个月前
已关闭
Comparison of the General Characteristics of Patients with Severe Asthma Who Switched from Omalizumab to Mepolizumab versus Patients Who Responded to Omalizumab Treatment: A Real-Life Study
4个月前
已完结
Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative study
4个月前
已完结
Dupilumab use in patients with hypereosinophilic syndromes: a multicenter case series and review of the literature
6个月前
已完结
Eosinophilic complications during dupilumab therapy for type 2 diseases: a systematic review
6个月前
已完结
Asthma loss of control after switch from anti-IL-5/5R drugs to dupilumab in severe eosinophilic asthma: A case series
6个月前
已关闭
Graves disease in a patient treated with dupilumab for severe asthma
7个月前
已完结
皖公网安备34019202002308
